Insider Trading History of Lieu Hsiao D

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lieu Hsiao D since 2012. This trader's CIK number is 1468482. At the time of last reporting, Lieu Hsiao D was the SVP, Chief Medical Officer of Ngm Biopharmaceuticals Inc. (stock ticker symbol NGM). Also see all insider trading activities at Ngm Biopharmaceuticals Inc.

Note that in the past Lieu Hsiao D also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ngm Biopharmaceuticals Inc (NGM) by Lieu Hsiao D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 NGM 0 $0 12,258 $283,934 10,000 $120,600
2020 NGM 0 $0 1,562 $34,364 0 $0

Yearly summary of insider trading at Capricor Therapeutics, Inc. (NLTX) by Lieu Hsiao D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 NLTX 12,500 $0 0 $0 0 $0


Insider trading activities at 2 companies by Lieu Hsiao D:

1. Ngm Biopharmaceuticals Inc (NGM)

2. Capricor Therapeutics, Inc. (NLTX)

Table 1. Insider trading of Ngm Biopharmaceuticals Inc (NGM) by Lieu Hsiao D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-10-05 NGM Option Ex 2,000 12.06 24,120
2021-10-05 NGM Sale 2,000 22.00 44,000
2021-08-12 NGM Sale 8,000 23.50 188,000
2021-08-11 NGM Sale 2,258 23.00 51,934
2021-08-12 NGM Option Ex 8,000 12.06 96,480
2020-05-15 NGM Sale 1,562 22.00 34,364

Table 2. Insider trading of Capricor Therapeutics, Inc. (NLTX) by Lieu Hsiao D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-03-30 NLTX Buy 12,500 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lieu Hsiao D (SVP, Chief Medical Officer of Ngm Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.